Company: ARWR
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038858
Chunk: 85

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 85
---
$7,754 $8,531 General and administrative expense449 537 1,442 1,504 Variable lease cost (1)Research and development893 863 2,830 2,478 General and administrative expense— — — — Total $3,575 $4,365 $12,026 $12,513 (1) Variable lease cost is primarily related to operating expenses associated with the Company’s operating leases.There was no short-term lease cost during the three and nine months ended June 30, 2025 and 2024, respectively. The following table presents maturities of operating lease liabilities on an undiscounted basis as of June 30, 2025:YearAmounts(in thousands)2025 (remainder)$3,902 202615,799 202714,974 202813,619 202913,905 2030 and thereafter114,790 Total$176,989 Less imputed interest$(64,289)Total operating lease liabilities (includes current portion)$112,700 Supplemental cash flow and other information related to leases was as follows:Three Months Ended June 30,Nine Months Ended June 30,2025202420252024(in thousands)Cash received for amounts included in the measurement of lease liabilities:Operating cash flows from operating leases$— $— $— $3,099 Right-of-use assets obtained in exchange for amended operating lease liabilities$— $— $— $(64)Cash paid for amounts included in the measurement of lease liabilities:Operating cash flows from operating leases$3,875 $3,204 $11,554 $7,221 June 30,20252024Weighted-average remaining lease term (in years)11.912.8Weighted-average discount rate8.0 %8.0 %

17

NOTE 9. STOCK-BASED COMPENSATION

The Company has three plans that provide for equity-based compensation.Under the 2013 Incentive Plan (the “2013 Plan”), 2,350,117 awards are granted and outstanding, relating to stock options and restricted stock awards to employees and directors as of June 30, 2025. Under the 2021 Incentive Plan (the “2021 Plan”), 8,000,000 shares (subject to certain adjustments) of the Company’s common stock are authorized for grants of stock options